Siblings Conference Papers/Meeting Abstract [3/3] Collection Statistics Item counts issued in 3 years:3(4.35%) Items With Fulltext:69(100.00%) Download counts of the item Download times greater than 0:69(100.00%) Download times greater than 100:67(97.10%) Total Bitstream Download Counts:47417(96.58%) Last Update: 2024-12-01 13:38 Top Upload Loading... Top Download Loading... Recent Submissions The application of emodin treatment... Screening and identification of emo... The dietary flavonol kaempferol inh... Emodin inhibits EBV reactivation an... Perspective: Contribution of Epstei... Epstein-Barr virus BRLF1 induces ge... Epstein-Barr Virus Rta-mediated acc... Inhibition of Epstein-Barr virus re... Luteolin inhibits Epstein-Barr viru... EBV reactivation as a target of lut...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-25 of 69. (3 Page(s) Totally) 1 2 3 > >> View [10|25|50] records per page

Date	Title	Relation
2024-02-21	The application of emodin treatment on nasopharyngeal carcinoma therapy	Biomedicines. 2024 Feb 21;12(3):Article number 486.
2023-07-13	Screening and identification of emodin as an EBV DNase inhibitor to prevent its biological functions	Virology Journal. 2023 Jul 13;20:Article number 148.
2022-12-23	The dietary flavonol kaempferol inhibits epstein-barr virus reactivation in nasopharyngeal carcinoma cells	Molecules. 2022 Dec 23;27(23):Article number 8158.
2019-11-15	Emodin inhibits EBV reactivation and represses NPC tumorigenesis	Cancers. 2019 Nov 15;11(11):Article number 1795.
2018-04-17	Perspective: Contribution of Epstein-Barr virus (EBV) reactivation to the carcinogenicity of nasopharyngeal cancer cells	Cancers. 2018 Apr 17;10(4):Article number 120.
2017-09-05	Epstein-Barr virus BRLF1 induces genomic instability and progressive malignancy in nasopharyngeal carcinoma cells	Oncotarget. 2017 Sep 5;8(45):78948-78964.
2017-08	Epstein-Barr Virus Rta-mediated accumulation of DNA methylation interferes with CTCF binding in both host and viral genomes	Journal of Virology. 2017 Aug;91(15):Article number e00736-17.
2017-01-05	Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin	Journal of Biomedical Science. 2017 Jan 5;24:Article number 2.
2016-08	Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes	Antiviral Research. 2016 Aug;132:99-110.
2016-03-08	EBV reactivation as a target of luteolin to repress NPC tumorigenesis	Oncotarget. 2016 Mar 8;7(14):18999-19017.
2015-01-23	EGCG Inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells	International Journal of Molecular Sciences. 2015 Jan 23;16(2):2530-2558.
2014-09	Epstein-barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma	Oncotarget. 2014 Sep;5(18):8583-8601.
2014-07	Epstein-Barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan	Cancer Epidemiology, Biomarkers and Prevention. 2014 Jul;23(7):1213-1219.
2014-03	LRIG1 modulates aggressiveness of head and neck cancers by regulating EGFR-MAPK-SPHK1 signaling and extracellular matrix remodeling	Oncogene. 2014 Mar;33(11):1375-1384.
2014-02	Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle	Journal of Virology. 2014 Feb;88(9):4962-4975.
2013-12-20	Reactive oxygen species mediate epstein-barr virus reactivation by N-methyl-n'-nitro-N-nitrosoguanidine	PLoS ONE. 2013 Dec 20;8(12):Article number e84919.
2013-12-05	Upregulation of endocan by Epstein-Barr Virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma	PLoS ONE. 2013 Dec 5;8(12):Article number e82254.
2013-12	Inhibition of epstein-barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane	Molecular Carcinogenesis. 2013 Dec;52(12):946-958.
2013-12	Microtubule depolymerization activates the Epstein-Barr virus lytic cycle through protein kinase C pathways in nasopharyngeal carcinoma cells	Journal of General Virology. 2013 Dec;94(Pt 12):2750-2758.
2013-03	Characterization of ELISA detection of broad-spectrum anti-Epstein–Barr virus antibodies associated with nasopharyngeal carcinoma	Journal of Medical Virology. 2013 Mar;85(3):524-529.
2012-09-14	The synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cells	PLoS ONE. 2012 Sep 14;7(9):Article number e44810.
2012-06	Epstein-barr virus BGLF4 kinase retards cellular S-phase progression and induces chromosomal abnormality	PLoS ONE. 2012 Jun;7(6):Article number e39217.
2012-02	Suppressive regulation of KSHV RTA with O-GlcNAcylation	Journal of Biomedical Science. 2012 Feb;19(1):Article number 12.
2012-01	Correlates of anti-EBV EBNA1 IgA positivity among unaffected relatives from nasopharyngeal carcinoma multiplex families	British Journal of Cancer. 2012 Jan;106(1):206-209.
2012-01	Epstein-Barr virus Rta-mediated transactivation of p21 and 14-3-3sigma arrests cells at the G1/s transition by reducing cyclin E/CDK2 activity	Journal of General Virology. 2012 Jan;93(1):139-149.

Showing items 1-25 of 69. (3 Page(s) Totally) 1 2 3 > >> View [10|25|50] records per page